Spencer Platt / Getty Images
The U.S. Department of Health and Human Services booked an unusual guest interviewer for one of its public health events this fall: Shulem Lemmer, the first Hasidic singer to sign with a major record label.
Lemmer has no particular expertise in public health, but he grew up in Brooklyn, home to many ultraorthodox Jews like himself. He s seen as a trusted messenger in parts of the Hasidic community that, despite suffering a disproportionate number of hospitalizations and deaths from COVID-19, have on some occasions resisted New York s pandemic restrictions.
In the end, the interview never aired HHS changed its mind about having entertainers explain COVID-19. Still, public health experts say the idea of enlisting respected and well-known leaders to help explain the health message is exactly the right way to disarm and persuade skeptics and more crucial than ever this winter as cases and deaths from the coronavirus surge all across the U.S .
Trusted Messengers, Trusted Messages : How To Overcome Vaccine Hesitancy
at 2:00 am NPR
The U.S. Department of Health and Human Services booked an unusual guest interviewer for one of its public health events this fall: Shulem Lemmer, the first Hasidic singer to sign with a major record label.
Lemmer has no particular expertise in public health, but he grew up in Brooklyn, home to many ultraorthodox Jews like himself. He s seen as a trusted messenger in parts of the Hasidic community that, despite suffering a disproportionate number of hospitalizations and deaths from COVID-19, have on some occasions resisted New York s pandemic restrictions.
Posted on 8538
Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.
Debra Furr-Holden is the Associate Dean for Public Health Integration and Director of the Flint Center for Health Equity Solutions, funded by the National Institute on Minority Health and Health Disparities (NIMHD; #U54MD011227). She also serves as the MSU Co-Director of the Healthy Flint Research Coordinating Center. She is an epidemiologist and classically-trained public health professional with expertise in drug and alcohol dependence epidemiology, psychiatric epidemiology, and prevention science. She attended Johns Hopkins University Krieger School of Arts and Sciences (BA Natural Sciences and Public Health, 1996) and Johns Hopkins Bloomberg School of Public Health (PhD, 1999).
In 2005, she initiated the Drug Investigations, Violence, and Environmental Studies Laboratory (The DIVE Studies Lab) at The Pacific Institute for Research and Evaluation. In 2007, the group moved to the Johns Hopkins Bloomberg School of Public Health. In January 2016, she moved back to Flint and became
Somatus Continues to Advance Kidney Care Model with Addition of Senior Scientific Advisor MCLEAN, Va. (Business Wire) Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.